PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Biperiden, 98%
CAS No P695-25mg
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 176,000¿ø
Æ÷Àå´ÜÀ§
Æ÷Àå´ÜÀ§





¡Ø È­Çиí : Biperiden, 98%

 

¡Ø µî±Þ : APIs and Bioactives > AChR Agonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 25mg , 100mg , 1g

 

¡Ø È­ÇÐ½Ä : C21H29NO

 

¡Ø CAS # : [514-65-8]

 

 

IDENTITY
CAS Registry #: [514-65-8]
MDL Number: MFCD05662335
MF: C21H29NO
MW: 311.46
SPECIFICATIONS & PROPERTIES
Purity: 98%
Available Spectra:

 

FT-IR, LCMS

Physical Form: Off white to beige powder
Melting Point: 234-246¡ÆC
Long-Term Storage:

 

Store at room temperature

Shipping: Not Regulated for Shipping

BIOLOGICAL INFO
Application(s): Antiparkinsonian agent of the anticholinergic type

REVIEW

Parkinsonism is thought to result from an imbalance between the excitatory (cholinergic) and inhibitory (dopaminergic) systems in the corpus striatum. The mechanism of action of centrally active anticholinergic drugs such as biperiden is considered to relate to competitive antagonism of acetylcholine at cholinergic receptors in the corpus striatum, which then restores the balance.

REFERENCES
[1] Nishiyama K, Mizuno T, Sakuta M, Kurisaki H: Chronic dementia in Parkinsons disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination. Adv Neurol. 1993;60:479-83.

Risk Description(s)
R36/37/38: Irritating to eyes, respiratory system and skin

Safety Description(s)
S24/25: Avoid contact with skin and eyes.